Antimicrobial

Phathom Pharmaceuticals Appoints Ted Schroeder to its Board of Directors

FLORHAM PARK, N.J., April 16, 2025 (GLOBE NEWSWIRE) -- Phathom Pharmaceuticals, Inc. (Nasdaq: PHAT), a biopharmaceutical company focused on developing…

8 months ago

Spectrum Vascular Welcomes New Executive Leadership

WHITE PLAINS, N.Y.--(BUSINESS WIRE)--Spectrum Vascular (“Spectrum” or the “Company”), a provider of vascular access and medication management products designed to…

8 months ago

Microban International Wins Silver Edison Award for Sustainable Antimicrobial Technology Ascera™

HUNTERSVILLE, N.C., April 10, 2025 /PRNewswire/ -- Microban International, the leader in antimicrobial solutions, has been awarded the silver Edison…

8 months ago

Theriva Biologics Announces Presentation of Data from the Phase 1b/2a Clinical Trial of SYN-004 (ribaxamase) in Allogeneic Hematopoietic Cell Transplant Recipients

Interim blinded safety and pharmacokinetic data to be presented at the Congress of the European Society of Clinical Microbiology and…

8 months ago

Recce Pharmaceuticals Announces A$5.0 million Placement & Launches A$10.8 million Entitlement Offer to Shareholders

A$5.0 million commitment received from Australian-based private investorA$10.8 million Entitlement Offer at the same offer price as the placementFunds to…

8 months ago

The ‘Father of Modern Food and Drug Law,’ Peter Hutt, Joins EVŌQ Nano Board of Directors

Hutt Brings Decades of Regulatory Insight to Help Advance Nanoparticle Technology Platform SALT LAKE CITY, April 9, 2025 /PRNewswire/ --…

8 months ago

Seegene Announces Development of CURECA™, a Next-Generation Fully Automated PCR Solution Featuring Customizable Pre-treatment Automation

- Seegene to showcase a conceptual video introducing CURECA™ at ESCMID Global 2025 — a full automation system expected to cover the entire…

8 months ago

Cepheid and Oxford Nanopore Technologies Partner to Advance Automated Sequencing-Based Solutions

Collaboration to leverage Oxford Nanopore's sequencing platform and Cepheid's GeneXpert system to advance the field of sequencing for infectious diseases…

8 months ago

Valneva and LimmaTech Announce First Vaccination in Phase 2 Infant Study of Tetravalent Shigella Vaccine Candidate S4V2

Saint Herblain (France) and Schlieren (Zurich), April 9, 2025 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine…

8 months ago

FendX Discusses CDC Recent Reports on the Rise of Antimicrobial Resistance

CDC reports antimicrobial resistance is an urgent global public health threat and, in the U.S., more than 2.8 million antimicrobial…

8 months ago